Want to join the conversation?
Biopharma company $REGN and Sanofi said placebo-controlled Phase 3 studies, LIBERTY AD SOLO 1 and SOLO 2, testing dupilumab in adults with moderate-to-severe atopic dermatitis met their main endpoints. Treatment with dupilumab as monotherapy were found to improve overall disease severity, skin clearing, itching, quality of life and mental health.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!